Leaflet TAMOXIFEN SANDOZ 10mg film-coated tablets


Indicated for: breast cancer

Route of administration: oral

Substance: tamoxifen (selective estrogen receptor modulator)

ATC: L02BA01 (Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Anti-estrogens)

Tamoxifen is a medication primarily used for the treatment and prevention of breast cancer, particularly hormone-sensitive forms (estrogen receptor-positive). It is a selective estrogen receptor modulator (SERM) that works by blocking the effects of estrogen on breast cells, thereby reducing the growth and spread of cancer cells.

Tamoxifen is used in the treatment of early-stage breast cancer, as well as advanced or metastatic cases. It is also prescribed to reduce the risk of breast cancer recurrence and to prevent breast cancer in women at high risk.

Side effects may include hot flashes, nausea, fatigue, vaginal dryness, mood changes, and, in rare cases, blood clots or endometrial cancer. It is important to take tamoxifen as prescribed by a doctor, with regular monitoring to detect potential complications.

General data about TAMOXIFEN SANDOZ 10mg

  • Substance: tamoxifen
  • Date of last drug list: 01-05-2026
  • Commercial code: W53654002
  • Concentration: 10mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 100
  • Product type: generic
  • Price: 44.66 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: SALUTAS PHARMA GMBH - GERMANIA
  • Holder: HEXAL AG - GERMANIA
  • Number: 2715/2010/02
  • Shelf life: 5 years

Pharmaceutical forms available for tamoxifen

Concentrations available for tamoxifen

  • 10mg
  • 20mg
  • 30mg
  • 40mg

Compensation lists for TAMOXIFEN SANDOZ 10mg Hexal

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

44.66 RON

44.66 RON

0.00 RON